Financial updates
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma
Jupiter, FL – [August 19, 2025] – Myosin Therapeutics, a biotechnology company developing novel therapies...
The latest news in the field of our research and development financing.